Research map: Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification

Back to the article

Papers in this map

  1. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data · Ethan G Cerami · 2012 · 18797 citations · Cited by this paper
  2. A patient-driven agenda for liver cirrhosis research · 2026 · Related
  3. Heparan Sulfate Proteoglycans · Sandrine Sarrazin · 2011 · 1543 citations · Cited by this paper
  4. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · 2026 · Related
  5. Global view of human protein glycosylation pathways and functions · Katrine T.-B. G. Schjoldager · 2020 · 1374 citations · Cited by this paper
  6. Toward a CKLM framework for integrated clinical trial design · 2026 · Related
  7. The interaction of hepatic lipid and glucose metabolism in liver diseases · Lars P. Bechmann · 2011 · 1013 citations · Cited by this paper
  8. Large language models for detecting colorectal polyps in endoscopic images—further research is required · 2026 · Related
  9. Oxygen Sensing, Homeostasis, and Disease · Gregg L. Semenza · 2011 · 999 citations · Cited by this paper
  10. USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · 2026 · Related
  11. Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal · Ino de Bruijn · 2023 · 920 citations · Cited by this paper
  12. Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · 2026 · Related
  13. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin · Luca Pellegrini · 2000 · 712 citations · Cited by this paper
  14. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · 2026 · Related
  15. Immune responses at the maternal-fetal interface · Stephanie E. Ander · 2019 · 668 citations · Cited by this paper
  16. Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · 2026 · Related
  17. Glycosylation: mechanisms, biological functions and clinical implications · Mengyuan He · 2024 · 479 citations · Cited by this paper
  18. Enhanced acetate uptake and metabolism in endothelial cells promote tumour angiogenesis and immunosuppression by increasing histone acetylation · 2026 · Related
  19. Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy · Heng‐Huan Lee · 2019 · 427 citations · Cited by this paper
  20. Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment · 2026 · Related
  21. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment · Fubo Zhou · 2017 · 407 citations · Cited by this paper
  22. Targeting Glycosylation: A New Road for Cancer Drug Discovery · Ana Filipa Costa · 2020 · 286 citations · Cited by this paper
  23. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States · Nabihah Tayob · 2022 · 229 citations · Cited by this paper
  24. Alteration of protein glycosylation in liver diseases · Bram Blomme · 2008 · 226 citations · Cited by this paper
  25. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis · Xiongjun Wang · 2019 · 226 citations · Cited by this paper
  26. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment · Stephanie van de Wall · 2020 · 226 citations · Cited by this paper
  27. A primate subfamily of galectins expressed at the maternal–fetal interface that promote immune cell death · Nándor Gábor Than · 2009 · 212 citations · Cited by this paper
  28. Glypicans as Cancer Therapeutic Targets · Nan Li · 2018 · 161 citations · Cited by this paper
  29. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies · Beatrice Maria Greco · 2022 · 153 citations · Cited by this paper
  30. Structural basis for FGF hormone signalling · Lingfeng Chen · 2023 · 146 citations · Cited by this paper
  31. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma · Wan‐Ling Ho · 2016 · 132 citations · Cited by this paper
  32. Altered glycosylation in cancer: molecular functions and therapeutic potential · Xuemeng Xu · 2024 · 125 citations · Cited by this paper
  33. A biological guide to glycosaminoglycans: current perspectives and pending questions · Sylvie Ricard‐Blum · 2024 · 118 citations · Cited by this paper
  34. Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma · Luan Sun · 2021 · 117 citations · Cited by this paper
  35. Lactic Acid: A Novel Signaling Molecule in Early Pregnancy? · Lina Ma · 2020 · 110 citations · Cited by this paper
  36. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells · Cegui Hu · 2024 · 101 citations · Cited by this paper
  37. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins · Zemin Ren · 2017 · 89 citations · Cited by this paper
  38. Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia · Nándor Gábor Than · 2014 · 86 citations · Cited by this paper
  39. Oxygen and placental development; parallels and differences with tumour biology · Graham J. Burton · 2017 · 82 citations · Cited by this paper

Source: OpenAlex (CC0)